These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31302499)

  • 1. Metabolic and endocrinal effects of N-desmethyl-olanzapine in mice with obesity: Implication for olanzapine-associated metabolic changes.
    Zhang X; Zhao Y; Shao H; Zheng X
    Psychoneuroendocrinology; 2019 Oct; 108():163-171. PubMed ID: 31302499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of obesity-associated metabolic disturbance by the antipsychotic drug olanzapine: Role of the autophagy-lysosome pathway.
    Zhang X; Zhao Y; Liu Y; Yuan Y; Shao H; Zheng X
    Biochem Pharmacol; 2018 Dec; 158():114-125. PubMed ID: 30291862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of olanzapine and N-desmethyl-olanzapine in plasma using a reversed-phase HPLC coupled with coulochemical detection: correlation of olanzapine or N-desmethyl-olanzapine concentration with metabolic parameters.
    Lu ML; Lin CH; Chen YC; Yang HC; Wu TH
    PLoS One; 2013; 8(5):e65719. PubMed ID: 23741510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia.
    An H; Fan H; Yun Y; Chen S; Qi S; Ma B; Shi J; Wang Z; Yang F
    Front Psychiatry; 2022; 13():930457. PubMed ID: 35800023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.
    Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A
    Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.
    Ballon JS; Pajvani UB; Mayer LE; Freyberg Z; Freyberg R; Contreras I; Rosenbaum M; Leibel RL; Lieberman JA
    J Psychopharmacol; 2018 May; 32(5):533-540. PubMed ID: 29444618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia.
    Lu ML; Chen CH; Kuo PT; Lin CH; Wu TH
    Schizophr Res; 2018 Mar; 193():139-145. PubMed ID: 28720417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Dose, Age, Sex, Body Weight, and Smoking on Plasma Concentrations of Olanzapine and N-desmethyl Olanzapine in Inpatients With Schizophrenia.
    An H; Fan H; Chen S; Qi S; Ma B; Shi J; Wang Z; Yang F
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):255-259. PubMed ID: 33814547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance.
    Li H; Fang M; Xu M; Li S; Du J; Li W; Chen H
    PLoS One; 2016; 11(12):e0167930. PubMed ID: 27973621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice.
    Coccurello R; Brina D; Caprioli A; Conti R; Ghirardi O; Schepis F; Moles A
    J Clin Psychopharmacol; 2009 Dec; 29(6):576-83. PubMed ID: 19910724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
    Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
    Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benserazide, an Inhibitor of Peripheral Kynurenine Metabolism, Attenuates Olanzapine-Induced Weight Gain, Insulin Resistance, and Dyslipidemia in C57Bl/6j Mice.
    Oxenkrug G; Summergrad P
    Mol Neurobiol; 2020 Jan; 57(1):135-138. PubMed ID: 31515691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Green Tea Extract on Systemic Metabolic Homeostasis in Diet-Induced Obese Mice Determined via RNA-Seq Transcriptome Profiles.
    Choi JY; Kim YJ; Ryu R; Cho SJ; Kwon EY; Choi MS
    Nutrients; 2016 Oct; 8(10):. PubMed ID: 27754422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Dietary Supplementation with Yerba Mate Ameliorates Diet-Induced Obesity and Metabolic Disorders in Mice by Regulating Energy Expenditure and Lipid Metabolism.
    Choi MS; Park HJ; Kim SR; Kim DY; Jung UJ
    J Med Food; 2017 Dec; 20(12):1168-1175. PubMed ID: 28872427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity exacerbates the acute metabolic side effects of olanzapine.
    Townsend LK; Peppler WT; Bush ND; Wright DC
    Psychoneuroendocrinology; 2018 Feb; 88():121-128. PubMed ID: 29241148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Effect of an Oriental Herbal Medicine on Obesity and Its Comorbidities with Transcriptional Responses in Diet-Induced Obese Mice.
    Choi JY; Kim YJ; Cho SJ; Kwon EY; Ryu R; Choi MS
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
    Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
    Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition.
    Ferreira V; Folgueira C; García-Altares M; Guillén M; Ruíz-Rosario M; DiNunzio G; Garcia-Martinez I; Alen R; Bookmeyer C; Jones JG; Cigudosa JC; López-Larrubia P; Correig-Blanchar X; Davis RJ; Sabio G; Rada P; Valverde ÁM
    Redox Biol; 2023 Jul; 63():102741. PubMed ID: 37230004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole.
    Shertzer HG; Kendig EL; Nasrallah HA; Johansson E; Genter MB
    Int J Obes (Lond); 2010 Jun; 34(6):970-9. PubMed ID: 20065957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.